1
van Leent, Merlijn W. J., Stevanovic, Jelena, Jansman, Frank G., Beinema, Maarten J., Brouwers, Jacobus R. B. J., Postma, Maarten J.
Veröffentlicht in: van Leent , M W J , Stevanovic , J , Jansman , F G , Beinema , M J , Brouwers , J R B J & Postma , M J 2015 , ' Cost-Effectiveness of Dabigatran Compared to Vitamin-K Antagonists for the Treatment of Deep Venous Thrombosis in the Netherlands Using Real-World Data ' , PLoS ONE , vol. 10 , no. 8 , e0135054 . https://doi.org/10.1371/journal.pone.0135054;
2015
Veröffentlicht in: van Leent , M W J , Stevanovic , J , Jansman , F G , Beinema , M J , Brouwers , J R B J & Postma , M J 2015 , ' Cost-Effectiveness of Dabigatran Compared to Vitamin-K Antagonists for the Treatment of Deep Venous Thrombosis in the Netherlands Using Real-World Data ' , PLoS ONE , vol. 10 , no. 8 , e0135054 . https://doi.org/10.1371/journal.pone.0135054;
2015
2
de Jong, Lisa Aniek, Gout-Zwart, Judith J, van den Bosch, Marina, Koops, Mike, Postma, Maarten J
Veröffentlicht in: de Jong , L A , Gout-Zwart , J J , van den Bosch , M , Koops , M & Postma , M J 2019 , ' Rivaroxaban for non-valvular atrial fibrillation and venous thromboembolism in the Netherlands : a real-world data based cost-effectiveness analysis ' , Journal of Medical Economics , vol. 22 , no. 4 , pp. 306-318 . https://doi.org/10.1080/13696998.2018.1563404;
2019
Veröffentlicht in: de Jong , L A , Gout-Zwart , J J , van den Bosch , M , Koops , M & Postma , M J 2019 , ' Rivaroxaban for non-valvular atrial fibrillation and venous thromboembolism in the Netherlands : a real-world data based cost-effectiveness analysis ' , Journal of Medical Economics , vol. 22 , no. 4 , pp. 306-318 . https://doi.org/10.1080/13696998.2018.1563404;
2019
3
4
Smits, E., Andreotti, F., Houben, E., Crijns, H.J.G.M., Haas, S., Spentzouris, G., Schink, T., Gini, R., Bartolini, C., Penning-van Beest, F., Herings, R.
Veröffentlicht in: Smits , E , Andreotti , F , Houben , E , Crijns , H J G M , Haas , S , Spentzouris , G , Schink , T , Gini , R , Bartolini , C , Penning-van Beest , F & Herings , R 2022 , ' Adherence and Persistence with Once-Daily vs Twice-Daily Direct Oral Anticoagulants Among Patients with Atrial Fibrillation: Real-World Analyses from the Netherlands, Italy and Germany ' , Drugs-Real World Outcomes , vol. 9 , no. 2 , pp. 199-209 . https://doi.org/10.1007/s40801-021-00289-w;
2022
Veröffentlicht in: Smits , E , Andreotti , F , Houben , E , Crijns , H J G M , Haas , S , Spentzouris , G , Schink , T , Gini , R , Bartolini , C , Penning-van Beest , F & Herings , R 2022 , ' Adherence and Persistence with Once-Daily vs Twice-Daily Direct Oral Anticoagulants Among Patients with Atrial Fibrillation: Real-World Analyses from the Netherlands, Italy and Germany ' , Drugs-Real World Outcomes , vol. 9 , no. 2 , pp. 199-209 . https://doi.org/10.1007/s40801-021-00289-w;
2022
5
Heisen, Marieke, Treur, Maarten J, Heemstra, Harald E, Giesen, Eric B W, Postma, Maarten J
Veröffentlicht in: Heisen , M , Treur , M J , Heemstra , H E , Giesen , E B W & Postma , M J 2017 , ' Cost-effectiveness analysis of rivaroxaban for treatment and secondary prevention of venous thromboembolism in the Netherlands ' , Journal of Medical Economics , vol. 20 , no. 8 , 0046-RT.R1/1331912 , pp. 813-824 . https://doi.org/10.1080/13696998.2017.1331912;
2017
Veröffentlicht in: Heisen , M , Treur , M J , Heemstra , H E , Giesen , E B W & Postma , M J 2017 , ' Cost-effectiveness analysis of rivaroxaban for treatment and secondary prevention of venous thromboembolism in the Netherlands ' , Journal of Medical Economics , vol. 20 , no. 8 , 0046-RT.R1/1331912 , pp. 813-824 . https://doi.org/10.1080/13696998.2017.1331912;
2017
6
Pisters, R., van Vugt, S. P. G., Brouwer, M. A., Elvan, A., ten Holt, W. L., Zwart, P. A. G., Kirchhof, P., Crijns, H. J. G. M., Hemels, M. E. W.
Veröffentlicht in: Pisters , R , van Vugt , S P G , Brouwer , M A , Elvan , A , ten Holt , W L , Zwart , P A G , Kirchhof , P , Crijns , H J G M & Hemels , M E W 2017 , ' Real-life use of Rivaroxaban in the Netherlands : data from the Xarelto for Prevention of Stroke in Patients with Atrial Fibrillation (XANTUS) registry ' , Netherlands Heart Journal , vol. 25 , no. 10 , pp. 551-558 . https://doi.org/10.1007/s12471-017-1009-9;
2017
Veröffentlicht in: Pisters , R , van Vugt , S P G , Brouwer , M A , Elvan , A , ten Holt , W L , Zwart , P A G , Kirchhof , P , Crijns , H J G M & Hemels , M E W 2017 , ' Real-life use of Rivaroxaban in the Netherlands : data from the Xarelto for Prevention of Stroke in Patients with Atrial Fibrillation (XANTUS) registry ' , Netherlands Heart Journal , vol. 25 , no. 10 , pp. 551-558 . https://doi.org/10.1007/s12471-017-1009-9;
2017
7
Chu, Gordon, Seelig, Jaap, Trinks-Roerdink, Emmy M., van Alem, Anouk P., Alings, Marco, van den Bemt, Bart, Boersma, Lucas V. A., Brouwer, Marc A., Cannegieter, Suzanne C., ten Cate, Hugo, Kirchhof, Charles J. H. J., Crijns, Harry J. G. M., van Dijk, Ewoud J., Elvan, Arif, van Gelder, Isabelle C., de Groot, Joris R., den Hartog, Frank R., de Jong, Jonas S. S. G., de Jong, Sylvie, Klok, Frederikus A., Lenderink, Timo, Luermans, Justin G., Meeder, Joan G., Pisters, Ron, Polak, Peter, Rienstra, Michiel, Smeets, Frans, Tahapary, Giovanni J. M., Theunissen, Luc, Tieleman, Robert G., Trines, Serge A., van der Voort, Pepijn, Geersing, Geert-Jan, Rutten, Frans H., Hemels, Martin Ew, Huisman, Menno
Veröffentlicht in: Chu , G , Seelig , J , Trinks-Roerdink , E M , van Alem , A P , Alings , M , van den Bemt , B , Boersma , L V A , Brouwer , M A , Cannegieter , S C , ten Cate , H , Kirchhof , C J H J , Crijns , H J G M , van Dijk , E J , Elvan , A , van Gelder , I C , de Groot , J R , den Hartog , F R , de Jong , J S S G , de Jong , S , Klok , F A , Lenderink , T , Luermans , J G , Meeder , J G , Pisters , R , Polak , P , Rienstra , M , Smeets , F , Tahapary , G J M , Theunissen , L , Tieleman , R G , Trines , S A , van der Voort , P , Geersing , G-J , Rutten , F H , Hemels , M E & Huisman , M 2020 , ' Design and rationale of DUTCH-AF : a prospective nationwide registry programme and observational study on long-term oral antithrombotic treatment in patients with atrial fibrillation ' , BMJ Open , vol. 10 , no. 8 , 036220 . https://doi.org/10.1136/bmjopen-2019-036220;
2020
Veröffentlicht in: Chu , G , Seelig , J , Trinks-Roerdink , E M , van Alem , A P , Alings , M , van den Bemt , B , Boersma , L V A , Brouwer , M A , Cannegieter , S C , ten Cate , H , Kirchhof , C J H J , Crijns , H J G M , van Dijk , E J , Elvan , A , van Gelder , I C , de Groot , J R , den Hartog , F R , de Jong , J S S G , de Jong , S , Klok , F A , Lenderink , T , Luermans , J G , Meeder , J G , Pisters , R , Polak , P , Rienstra , M , Smeets , F , Tahapary , G J M , Theunissen , L , Tieleman , R G , Trines , S A , van der Voort , P , Geersing , G-J , Rutten , F H , Hemels , M E & Huisman , M 2020 , ' Design and rationale of DUTCH-AF : a prospective nationwide registry programme and observational study on long-term oral antithrombotic treatment in patients with atrial fibrillation ' , BMJ Open , vol. 10 , no. 8 , 036220 . https://doi.org/10.1136/bmjopen-2019-036220;
2020
8
Jacobs, Maartje S, Schouten, Jeroen F, de Boer, Pieter T, Hoffmann, Mikael, Levin, Lars-Åke, Postma, Maarten J
Veröffentlicht in: Jacobs , M S , Schouten , J F , de Boer , P T , Hoffmann , M , Levin , L-Å & Postma , M J 2018 , ' Secondary adherence to non-vitamin-K antagonist oral anticoagulants in patients with atrial fibrillation in Sweden and the Netherlands ' , Current Medical Research and Opinion , vol. 34 , no. 10 , pp. 1839-1847 . https://doi.org/10.1080/03007995.2018.1459528;
2018
Veröffentlicht in: Jacobs , M S , Schouten , J F , de Boer , P T , Hoffmann , M , Levin , L-Å & Postma , M J 2018 , ' Secondary adherence to non-vitamin-K antagonist oral anticoagulants in patients with atrial fibrillation in Sweden and the Netherlands ' , Current Medical Research and Opinion , vol. 34 , no. 10 , pp. 1839-1847 . https://doi.org/10.1080/03007995.2018.1459528;
2018
9
10
Le, H.H., Pechlivanoglou, P., Postma, M.J.
Veröffentlicht in: Le , H H , Pechlivanoglou , P & Postma , M J 2013 , ' Indirect treatment comparison and economic evaluation of novel oral anticoagulants for the prevention of stroke in patients with atrial fibrillation in the Netherlands ' , Value in Health , vol. 16 , no. 7 , pp. A514 . https://doi.org/10.1016/j.jval.2013.08.1213;
2013
Veröffentlicht in: Le , H H , Pechlivanoglou , P & Postma , M J 2013 , ' Indirect treatment comparison and economic evaluation of novel oral anticoagulants for the prevention of stroke in patients with atrial fibrillation in the Netherlands ' , Value in Health , vol. 16 , no. 7 , pp. A514 . https://doi.org/10.1016/j.jval.2013.08.1213;
2013